Podcast · 3 episodes in the reference, 2025 to 2026
Published by BiotechTV
| Episode 48: Blackstone's Kiran Reddy | Kiran Reddy | 21 September 2026 | Blackstone's Senior Managing Director Kiran Reddy describes his early life and education, and the impact that patient care has had on his approach to investing. He describes notable investments in neuroscience, and a stop at Biogen, before returning to investing at Clarus, which was acquired by Blackstone. He recalls the unique opportunity he saw when a company with the resources of Blackstone decided to go big into life sciences. | |
| Episode 40: GV's Krishna Yeshwant | Krishna Yeshwant | 18 May 2026 | He describes his well-rounded background of studying and working in both software in Silicon Valley and Medicine in Boston, and the start of GV. He describes a conservative start to investing at GV, but also today how Alphabet's scale and cash gives them the ability to ride cycles and make concentrated bets on companies the team has conviction on. | |
| Episode 23: a16z's Vineeta Agarwala | Vineeta Agarwala | 28 July 2025 | Still a practicing physician today, Vineeta Agarwala describes her educational background and early career, including experiences at the Broad Institute, Flatiron Health, and GV (Google Ventures). She talks about a16z's investment philosophy of "providing more than just a check," and a recent $500M fund partnered with Lilly. |